Last reviewed · How we verify
NCT03241758
Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy
trial testing Doppler ultrasound in Prostatic Neoplasms in 110 participants. Completed in 2 August 2017.
2 August 2017
Quick facts
| Lead sponsor | Corporacion Parc Tauli |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 110 |
| Start date | 29 November 2011 |
| Primary completion | 2 August 2017 |
| Estimated completion | 2 August 2017 |
Drugs / interventions tested
- Doppler ultrasound
Conditions studied
- Prostatic Neoplasms — all drugs for Prostatic Neoplasms →
- Erectile Dysfunction Following Radical Prostatectomy — all drugs for Erectile Dysfunction Following Radical Prostatectomy →
Sponsor
Corporacion Parc Tauli — full company profile →
Who can join
Adults 18 to 80, male only, with Prostatic Neoplasms or Erectile Dysfunction Following Radical Prostatectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A study designed to evaluate vascular changes after radical laparoscopic prostatectomy using Doppler ultrasound and the impact of such changes on erectile function and quality of life of patients. The baseline study will be compared with the study one year after surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03241758
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Doppler ultrasound
Trials testing the same drug.
- NCT07385976 — The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients · not yet recruiting
- NCT05720169 — Fetal, Obstetrics and Reproduction Genomics · unknown
- NCT06140160 — Anterior Thoracic Perforating Artery (PATA); Systematization and Applications in Reconstructive Surgery of the Head and · NA · unknown
- NCT05743738 — Description of Septic Thrombophlebitis on Central Venous Catheter and Midline · NA · recruiting
- NCT05206942 — Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy · NA · recruiting
Other recruiting trials for Prostatic Neoplasms
Currently open trials in the same condition.
- NCT07285057 — Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance · Phase 2 · recruiting
- NCT07319871 — A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer · Phase 1 · recruiting
- NCT07335224 — Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture · NA · recruiting
- NCT07451002 — A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France · recruiting
- NCT06547398 — Prostate Adaptive Radiation Therapy · NA · recruiting
Other Corporacion Parc Tauli trials
Trials by the same sponsor.
- NCT07331805 — Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study · NA · not yet recruiting
- NCT06873360 — Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients · completed
- NCT06900335 — Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact · completed
- NCT06511700 — Implementation of the Intravitreal Injection Administered by Nurses · enrolling by invitation
- NCT07298720 — Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03241758 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Corporacion Parc Tauli
- Last refreshed: 7 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03241758.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing